Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
View ORCID ProfileYael Gurevich, View ORCID ProfileYoav Ram, View ORCID ProfileLilach Hadany
doi: https://doi.org/10.1101/2021.02.20.21252133
Yael Gurevich
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Yoav Ram
2School of Zoology, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Lilach Hadany
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel

Data Availability
The code used to produce the results is available upon request.
Posted February 23, 2021.
Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Yael Gurevich, Yoav Ram, Lilach Hadany
medRxiv 2021.02.20.21252133; doi: https://doi.org/10.1101/2021.02.20.21252133
Subject Area
Subject Areas
- Addiction Medicine (179)
- Allergy and Immunology (433)
- Anesthesia (99)
- Cardiovascular Medicine (948)
- Dermatology (109)
- Emergency Medicine (260)
- Epidemiology (8982)
- Gastroenterology (419)
- Genetic and Genomic Medicine (1949)
- Geriatric Medicine (190)
- Health Economics (401)
- Health Informatics (1328)
- Health Policy (659)
- Hematology (212)
- HIV/AIDS (420)
- Medical Education (200)
- Medical Ethics (54)
- Nephrology (222)
- Neurology (1825)
- Nursing (109)
- Nutrition (272)
- Oncology (997)
- Ophthalmology (297)
- Orthopedics (111)
- Otolaryngology (182)
- Pain Medicine (126)
- Palliative Medicine (44)
- Pathology (265)
- Pediatrics (579)
- Primary Care Research (234)
- Public and Global Health (4120)
- Radiology and Imaging (675)
- Respiratory Medicine (548)
- Rheumatology (224)
- Sports Medicine (177)
- Surgery (207)
- Toxicology (39)
- Transplantation (109)
- Urology (80)